1-241497861-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000143.4(FH):c.1500G>A(p.Trp500*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000143.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.1500G>A | p.Trp500* | stop_gained | Exon 10 of 10 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hereditary leiomyomatosis and renal cell cancer Pathogenic:1
- -
not provided Pathogenic:1
This variant is denoted FH c.1500G>A at the cDNA level and p.Trp500Ter (W500X) at the protein level. The substitution creates a nonsense variant, which changes a Tryptophan to a premature stop codon (TGG>TGA), and is predicted to cause loss of normal protein function through protein truncation. Also published as FH c.1371G>A (p.Trp457X) using alternate nomenclature, this variant has been reported in a large family with HLRCC as well as in an individual with a single cutaneous leiomyoma (Gardie 2011, Buelow 2016). In addition, the adjacent nucleotide change resulting in the same nonsense variant c.1499G>A (p.W500X), reported as p.W458X using alternate nomenclature, was identified in the compound heterozygous state with another FH variant in a child with fumarate hydratase deficiency and significantly decreased FH enzyme activity (Coughlin 1998). Based on currently available evidence, we consider FH c.1500G>A to be pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W500* pathogenic variant (also known as c.1500G>A), located in coding exon 10 of the FH gene, results from a G to A substitution at nucleotide position 1500. This changes the amino acid from a tryptophan to a stop codon within coding exon 10. This alteration occurs at the 3' terminus of theFH gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 2%/10 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This alteration disrupts normal FH folding and is anticipated to result in a significant decrease in structural stability (Ambry internal data). This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with FH-related disease and segregates with disease in one of these families (Ambry internal data; Gardie B et al. J. Med. Genet., 2011 Apr;48:226-34; Buelow B et al. Am. J. Surg. Pathol., 2016 07;40:982-8). This alteration is also referred to as p.Trp457X (c.1371G>A) in the literature. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at